Patents by Inventor Martine Poncelet

Martine Poncelet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6908914
    Abstract: The invention relates to benzene derivatives, to pharmaceutical compositions containing them, to processes for preparing them, and to the method of use thereof in the treatment of psychotic disorders.
    Type: Grant
    Filed: June 27, 2000
    Date of Patent: June 21, 2005
    Assignee: Sanofi-Synthelabo
    Inventors: Robert Boigegrain, Martine Bourrie, Pierre Lair, Raymond Paul, Martine Poncelet, Jean Claude Vernieres
  • Patent number: 5296596
    Abstract: The present invention relates to hexahydroazepine derivatives of formula ##STR1## in which: A=--CO--CH.sub.2 --, --CH(OH)--CH.sub.2 --; --CH.sub.2 --CH.sub.2 --; --CH.dbd.CH--; --C.tbd.C--;X=H or a halogen;Y=cyclohexyl or, when X is H, phenyl.It likewise relates to the salts of the said derivatives, to a process for the preparation of these and to the pharmaceutical compositions containing them, more particularly as antipsychotic agents.
    Type: Grant
    Filed: April 14, 1993
    Date of Patent: March 22, 1994
    Assignee: ELF SANOFI
    Inventors: Serge Lavastre, Jean-Pierre Maignan, Raymond Paul, Martine Poncelet, Vincent Santucci
  • Patent number: 5231092
    Abstract: The present invention relates to hexahydroazepine derivatives of formula ##STR1## in which: A=--CO--CH.sub.2 --, --CH(OH--CH.sub.2 --; --CH.sub.2 --CH.sub.2 --CH.sub.2 --;--CH.dbd.CH--; --C.tbd.C--;X=H or a halogen;Y=cylcohexyl or, when X is H, phenyl.It likewise relates to the salts of the said derivatives, to a process for the preparation of these and to the pharmaceutical compositions containing them, more particularly as antipsychotic agents.
    Type: Grant
    Filed: June 13, 1991
    Date of Patent: July 27, 1993
    Assignee: Sanofi
    Inventors: Serge Lavastre, Jean-Pierre Maignan, Raymond Paul, Martine Poncelet, Vincent Santucci
  • Patent number: 5043352
    Abstract: A method of treatment of depressive states which comprises administering in mammals in need thereof an effective amount of a compound ##STR1## R.sub.1 represents hydrogen, a halogen atom, a cyano group a nitro group, an acetyl group or a trifluoromethyl group;R.sub.2 represents a hydroxyl group, in which case R.sub.3 represents a hydrogen atom, or R.sub.2 and R.sub.3 taken together represent an additional bond between the carbon atoms by which they are carried; andR.sub.4 represents a 2-oxopyrrolidin-1-yl or 2-oxopiperid-1-yl group or a heterocyclic group selected from 1H-pyrid-2-on-1-yl, 1H-pyridazin-6-on-1-yl, 1H-pyrimidin-2-on-1-yl, 1H-pyrimidin-6-on-1-yl, 1H-pyrazin-2-on-1-yl and 1H-thiopyrid-2-on-1-yl groups which are unsubstituted or monosubstituted or disubstituted by a C.sub.1 -C.sub.4 alkyl group, a halogen atom or a hydroxyl, nitro, amino or carboxyl group and the pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: November 22, 1989
    Date of Patent: August 27, 1991
    Assignee: Sanofi
    Inventors: Philippe Soubrie, Martine Poncelet